Skip to main content

Advertisement

Log in

Role of serum holotranscobalamin (holoTC) in the diagnosis of patients with low serum cobalamin. Comparison with methylmalonic acid and homocysteine

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Plasma holotranscobalamin (holoTC) transports active cobalamin. Decreased levels of holoTC have been considered to be the earliest marker of cobalamin (Cbl) deficiency. In this work, holoTC was evaluated in low or borderline serum Cbl (LB12) and a concordance analysis was carried out with methylmalonic acid (MMA) and homocysteine (Hcy). Levels of Cbl, holoTC, MMA, and Hcy were investigated in a reference group in 106 patients with LB12 (≤200 pmol/l) and in 27 with folate deficiency (FOL). HoloTC levels were evaluated by an automated immunoassay (Active B12, Abbott Lab, Abbott Park, IL, USA). Lower levels of holoTC were observed in both LB12 and FOL groups (reference group vs LB12; p < 0.0001. Reference group vs FOL; p = 0.002). HoloTC levels were lower in LB12 than in FOL (p = 0.001). In LB12, concordance between Hcy and MMA was 82.1 % (chi-square test, p < 0.001; Kappa Index, 0.64, p < 0.0001). Concordance between Hcy and holoTC was 62 % (chi-square test, p = 0.006; Kappa index, 0.245, p = 0.006). Concordance between holoTC and MMA was 55.6 % (p = 0.233). Some cases with LB12 and elevated MMA did not show decreased holoTC. By contrast, MMA and Hcy were not increased in some patients with low holoTC and LB12. In conclusion, levels of holoTC were decreased in LB12 and FOL. In LB12 patients, holoTC concordance with MMA was poor. MMA/Hcy levels were not increased in a significant number of subjects with LB12 and low holoTC. This profile was found in iron deficiency. The significance of these changes remains to be clarified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Carmel R (2008) How I treat cobalamin (vitamin B12) deficiency. Blood 15(112):2214–2221

    Article  Google Scholar 

  2. Carmel R, Agrawal YP (2012) Failures of cobalamin assays in pernicious anemia. N Engl J Med 367:385–386

    Article  CAS  PubMed  Google Scholar 

  3. Chan CWJ, Liu SYH, Kho CSB et al (2007) Diagnostic clues to megaloblastic anaemia without macrocytosis. Int J Lab Hematol 29:163–171

    Article  CAS  PubMed  Google Scholar 

  4. Allen LH (2009) How common is vitamin B-12 deficiency? Am J Clin Nutr 89(suppl):693S–696S

    Article  CAS  PubMed  Google Scholar 

  5. Remacha AF, Montagud M, Cadafalch J, Riera A, Martino R, Gimferrer E (1993) Vitamin B12 transport proteins in patients with HIV-1 infection and AIDS. Haematologica 78:84–88

    CAS  PubMed  Google Scholar 

  6. Hermann W, Obeid R (2013) Special issue on advances and controversies in B vitamins and choline. Clin Chem Leb Med 51:455–456

    Google Scholar 

  7. Bailey RL, Carmel R, Green R, Pfeiffer CM, Cogswell ME, Osterloh JD, Sempos CT, Yetley EA (2011) Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. Am J Clin Nutr 94:552–561

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, Brody LC, Carmel R, Curtin LR, Durazo-Arvizu RA, Eckfeldt JH, Green R, Gregory JF 3rd, Hoofnagle AN, Jacobsen DW, Jacques PF, Lacher DA, Molloy AM, Massaro J, Mills JL, Nexo E, Rader JI, Selhub J, Sempos C, Shane B, Stabler S, Stover P, Tamura T, Tedstone A, Thorpe SJ, Coates PM, Johnson CL, Picciano MF (2011) Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr 94:313S–321S

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Clarke R, Sherliker P, Hin H, Molloy AM, Nexo E, Ueland PM, Emmens K, Scott JM, Evans JG (2008) Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr 100:1054–1059

    Article  CAS  PubMed  Google Scholar 

  10. Smith AD, Refsum H (2012) Do we need to reconsider the desirable blood level of vitamin B12? J Intern Med 271:179–182

    Article  CAS  PubMed  Google Scholar 

  11. Carmel R (2011) Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 94:348S–358S

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Carmel R (2002) Measuring and interpreting holo-transcobalamin (holotranscobalamin II). Clin Chem 48:407–409

    CAS  PubMed  Google Scholar 

  13. Nexo E, Hoffmann-Lücke E (2011) Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 94:359S–365S

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Lindemans J, Schoester M, van Kapel J (1983) Application of a simple immunoadsorption assay for the measurement of saturated and unsaturated transcobalamin II and R-binders. Clin Chim Acta 132:53–61

    Article  CAS  PubMed  Google Scholar 

  15. Carmel R (1985) The distribution of endogenous cobalamin among cobalamin-binding proteins in the blood in normal and abnormal states. Am J Clin Nutr 41:713–719

    CAS  PubMed  Google Scholar 

  16. Herzlich B, Herbert V (1988) Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance. Lab Invest 58:332–337

    CAS  PubMed  Google Scholar 

  17. Herbert V, Fong W, Gulle V, Stopler T (1990) Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS. Am J Hematol 34:132–139

    Article  CAS  PubMed  Google Scholar 

  18. Herbert V (1994) Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 59(5 Suppl):1213S–1222S

    CAS  PubMed  Google Scholar 

  19. Wickramasinghe SN, Ratnayaka ID (1996) Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis. J Clin Pathol 49:755–758

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Wickramasinghe SN, Fida S (1993) Correlations between holo-transcobalamin II, holo-haptocorrin, and total B12 in serum samples from healthy subjects and patients. J Clin Pathol 46:537–539

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Goringe A, Ellis R, McDowell I, Vidal-Alaball J, Jenkins C, Butler C, Worwood M (2006) The limited value of methylmalonic acid, homocysteine and holotranscobalamin in the diagnosis of early B12 deficiency. Haematologica 91:231–234

    CAS  PubMed  Google Scholar 

  22. Morkbak AL, Heimdal RM, Emmens K, Molloy A, Hvas AM, Schneede J, Clarke R, Scott JM, Ueland PM, Nexo E (2005) Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project. Clin Chem Lab Med 43:1058–1064

    Article  CAS  PubMed  Google Scholar 

  23. Brady J, Wilson L, McGregor L, Valente E, Orning L (2008) Active B12: a rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer. Clin Chem 54:567–573

    Article  CAS  PubMed  Google Scholar 

  24. Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM (2011) Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem 57:856–863

    Article  CAS  PubMed  Google Scholar 

  25. Remacha AF, Souto JC, Piñana JL, Sardà MP, Queraltó JM, Martí-Fabregas J, García-Moll X, Férnandez C, Rodriguez A, Cuesta J (2011) Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study. Int J Hematol 93:458–464

    Article  PubMed  Google Scholar 

  26. Fedosov SN (2010) Metabolic signs of vitamin B(12) deficiency in humans: computational model and its implications for diagnostics. Metabolism 59:1124–1138

    Article  CAS  PubMed  Google Scholar 

  27. Heil SG, de Jonge R, de Rotte MC, van Wijnen M, Heiner-Fokkema RM, Kobold AC, Pekelharing JM, Adriaansen HJ, Sanders E, Trienekens PH, Rammeloo T, Lindemans J (2012) Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study. Ann Clin Biochem 49(Pt 2):184–189

    Article  CAS  PubMed  Google Scholar 

  28. Clarke R, Sherliker P, Hin H, Nexo E, Hvas AM, Schneede J, Birks J, Ueland PM, Emmens K, Scott JM, Molloy AM, Evans JG (2007) Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin. Clin Chem 53:963–970

    Article  CAS  PubMed  Google Scholar 

  29. Schrempf W, Eulitz M, Neumeister V, Siegert G, Koch R, Reichmann H, Storch A (2011) Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes. J Neurol 258:393–401

    Article  CAS  PubMed  Google Scholar 

  30. Stabler SP (2013) Vitamin B12 deficiency. N Engl J Med 368:149–160

    Article  CAS  PubMed  Google Scholar 

  31. Gonzalez-Gross M, Sola R, Albers U, Barrios L, Alder M, Castillo MJ, Pietrzik K (2007) B-vitamins and homocysteine in Spanish institutionalized elderly. Int J Vitam Nutr Res 77:22–33

    Article  CAS  PubMed  Google Scholar 

  32. Albers U, Palacios G, Pedrero-Chamizo R, Meléndez A, Pietrzik K, González-Gross M (2012) Polymedication in institutionalized elderly and its effect on vitamin B12, folate, and homocysteine levels. Nutr Hosp 27:298–302

    CAS  PubMed  Google Scholar 

  33. Vogel T, Dali-Youcef N, Kaltenbach G, Andrès E (2009) Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 63:1061–1067

    Article  CAS  PubMed  Google Scholar 

  34. Garrod MG, Allen LH, Haan MN, Green R, Miller JW (2010) Transcobalamin C776G genotype modifies the association between vitamin B12 and homocysteine in older Hispanics. Eur J Clin Nutr 64(5):3–9

    Article  Google Scholar 

  35. Riedel BM, Molloy AM, Meyer K, Fredriksen A, Ulvik A, Schneede J, Nexø E, Hoff G, Ueland PM (2011) Transcobalamin polymorphism 67A- > G, but not 776C- > G, affects serum holotranscobalamin in a cohort of healthy middle-aged men and women. J Nutr 141:1784–1790

    Article  CAS  PubMed  Google Scholar 

  36. Castro R, Barroso M, Rocha M, Esse R, Ramos R, Ravasco P, Rivera I, de Almeida IT (2010) The TCN2 776CNG polymorphism correlates with vitamin B(12) cellular delivery in healthy adult populations. Clin Biochem 43:645–649

    Article  CAS  PubMed  Google Scholar 

  37. Chen X, Remacha AF, Sarda MP, Carmel R (2005) Influence of cobalamin deficiency compared with that of cobalamin absorption on serum holotranscobalamin II. Am J Clin Nutr 81:110–114

    CAS  PubMed  Google Scholar 

  38. Obeid R, Kuhlmann M, Kirsch CM, Herrmann W (2005) Cellular uptake of vitamin B12 in patients with chronic renal failure. Nephron Clin Pract 99:c42–c48

    Article  CAS  PubMed  Google Scholar 

  39. Adaikalakoteswari A, Rabbani N, Waspadji S, Tjokroprawiro A, Kariadi SH, Adam JM, Thornalley PJ (2012) Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia-link to renal status, glycemic control and vascular inflammation. Diabetes Res Clin Pract 95:415–424

    Article  CAS  PubMed  Google Scholar 

  40. Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, Lahad A (2005) Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica 90:585–595

    CAS  PubMed  Google Scholar 

  41. Carmel R (2011) Mandatory fortification of the food supply with cobalamin: an idea whose time has not yet come. J Inherit Metab Dis 34:67–73

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Hvas AM, Morkbak AL, Nexo E (2007) Plasma holotranscobalamin compared with plasma cobalamins for assessment of vitamin B12 absorption; optimisation of a non-radioactive vitamin B12 absorption test (CobaSorb). Clin Chim Acta 376:150–154

    Article  CAS  PubMed  Google Scholar 

  43. Bhat DS, Thuse NV, Lubree HG, Joglekar CV, Naik SS, Ramdas LV, Johnston C, Refsum H, Fall CH, Yajnik CS (2009) Increases in plasma holotranscobalamin can be used to assess vitamin B-12 absorption in individuals with low plasma vitamin B-12. J Nutr 139:2119–2123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Hvas AM, Morkbak AL, Hardlei TF, Nexo E (2011) The vitamin B12 absorption test, CobaSorb, identifies patients not requiring vitamin B12 injection therapy. Scand J Clin Lab Invest 71:432–438

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. F. Remacha.

Additional information

All procedures followed were in accordance with the ethical standards of our institutional committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All persons gave their informed consent prior to their inclusion in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 90 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Remacha, A.F., Sardà, M.P., Canals, C. et al. Role of serum holotranscobalamin (holoTC) in the diagnosis of patients with low serum cobalamin. Comparison with methylmalonic acid and homocysteine. Ann Hematol 93, 565–569 (2014). https://doi.org/10.1007/s00277-013-1905-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1905-z

Keywords

Navigation